Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

President Donald Trump has signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of ...

President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...

The Trump administration said it would lower drug costs by tying them to the lowest ... 33 other Organization for Economic Co-operation and Development (OECD) countries. "Given that fact, this ...

“For years, pharmaceutical and drug companies have said research and development costs were what they are,” Trump said at a Monday press conference. “And for no reason whatsoever, they had ...

On Sunday, Trump took aim at the industry again, writing that the “Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs ...

AI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it ...

On average, Americans pay nearly four times more than other countries for their prescription drugs, effectively subsidizing pharmaceutical companies’ research and development costs for others ...

As in negotiations with foreign nations, minor concessions by drug companies are more likely than a true overhaul.